Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension

Seminars in Ophthalmology

Volumn 28, Issue 2, 2013, Pages 61-67

  Kim, Gyu Nam ^a   Han, Yong Seop ^a,b   Chung, In Young ^a,b   Seo, Seong Wook ^a,b   Park, Jong Moon ^a,b   Yoo, Ji Myong ^a,b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Anti glaucomatic agent; Bevacizumab; Intraocular pressure; Intravitreal injection; Ranibizumab

Indexed keywords

BEVACIZUMAB; BRINZOLAMIDE PLUS TIMOLOL; DORZOLAMIDE PLUS TIMOLOL; ELAZOP; RANIBIZUMAB; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADMINISTRATION, TOPICAL; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIHYPERTENSIVE AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; RETINAL DISEASES; SULFONAMIDES; THIAZINES; THIOPHENES; TIMOLOL; TONOMETRY, OCULAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874640819     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2012.754479     Document Type: Article

References (30)

1. Lee YJ, Park HJ, Lee TG, et al. Primary combined photodynamic therapy and intravitreal bevacizumab injection for neovascular age-related macular degeneration. J Korean Ophthalmol Soc 2010;051:35-41.
2. Smit DP, Meyer D. Intravitreal bevacizumab: An analysis of the evidence. Clin Ophthalmology 2007;1:273-284.
3. Matri L, Chebil A, Kort F, et al. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2010;248:779-784.
4. Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol 2010;21:178-183.
5. Nunes RP, Nóbrega MJ, De Novelli FJ, et al. Causes of interruption of bevacizumab therapy in age-related macu-lar degeneration. Arq Bras Oftalmol 2010;73:146-149.
6. Park HY, Yi KY, Kim HK. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Korean J Ophthalmol 2005;19:122-127.
7. Ziad FB, Abdallah MT, Christelle PE, et al. Intravitreal triamcinolone acetonide: pattern of secondary intraocular pressure rise and possible risk factors. Clin Ophthalmol 2008;2:269-274.
8. Pong JC. Anterior chamber paracentesis in patients with acute elevation of intraocular pressure. Graefes Arch Clin Exp Ophthalmol 2008;246:463-464.
9. Arnavielle S, Creuzot-Garcher C, Bron AM. Anterior chamber paracentesis in patients with acute elevation of intraocular pressure. Graefes Arch Clin Exp Ophthalmol 2007;245:345-350.
10. Cheung MG, Durrani OG, Murray PI. The safety of anterior chamber paracentesis in patients with uveitis. Br J Ophthalmol 2004;88:582-583.
11. Lee SJ, Lee JJ, Kim SD. Multiple retinal hemorrhage following anterior chamber paracentesis in uveitic glaucoma. Korean J Ophthalmol 2006;20:128-130.
12. Astam N, Batioglu F, Ozmert E. Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion. Int Ophthalmol 2009;29:543-548.
13. Avery RI, Pearlman, J Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695.
14. Atchaneeyasakul LO, Trinavarat A. Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity. J Perinatol 2010;30:497-499.
15. Brouzas D, Koutsandrea C, Moschos M, et al. Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin) for AMD followed by controlateral sympathetic ophthalmia. Clin Ophthalmol 2009;3:457-459.
16. Artunay O, Yuzbasioglu E, Rasier R, et al. Incidence and management of acute endophthalmitis after intravi-treal bevacizumab (Avastin) injection. Eye (Lond) 2009; 23:2187-2193.
17. Sharei V, Hohn F, Kohler T, et al. Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis). Eur J Ophthalmol 2010;20:174-179.
18. Adelman R, Zheng Q, Mayer HR. Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections. J Ocul Pharmacol Ther 2010;26:105-110.
19. Chang W, Chung M. Efficacy of anterior chamber para-centesis in intravitreal tramcinolone injection. Eur J Ophthalmol 2007;17:776-779.
20. Seong HK, Lee JM, Park YS, et al. Immediate national course of IOP after IVTA and the effect of preoperative ocular massage. J Korean Ophthalmol Soc 2007;48:808-814.
21. Theoulakis PE, Lepidas J, Petropoulos IK, et al. Effect of brimonidine/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab. Klin Monbi Augenheilkd 2010; 227:280-284.
22. Maurizio G, Carlo S, Maria, S, et al. Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure. J Glaucoma 2009;18:658-661.
23. Shonat RD, Wilson DF, Riva CE, et al. Effect of acute increase in intraocular pressure on intravascular optic nerve head-oxygen tension in cats. Investigative Ophthalmol Vis Sci 1992;33:3174-3180.
24. Calugaru D, Calugaru M. Fixed combinations of glaucoma medications. Oftalmologia 2008;52:23-31.
25. Yeh J, Kravitz D, Francis B. Rational use of the fixed combination of dorzolamide-timolol in the management of raised intraocular pressure and glaucoma. Clin Ophthalmol 2008;2:389-399.
26. Shim JC, Choe CM, Seong GJ. A comparision of short term use effects and safety of timoptic with those of cosopt in normal Korean. J Korean Ophthalmol Soc 2002;43:1206-1211.
27. Miglior S, Grunden JW, Kwok K. Efficacy and safety of fixed combinations of latanoprost/timolol and dorzola-mide/timolol in open-angle glaucoma or ocular hypertension. Eye 2010;24:1234-1242.
28. Miguel AT, Stefano M, Guna L, et al. Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol 2009;3:629-636.
29. Eakins KE, Whitelocke RAF, Bennett A, Martenet AC. Prostaglandin-like activity in ocular inflammation. Br Med J 1972;3:452.
30. Jampol LM. Aphakic cystoids macular edema: a hypothesis. Arch Ophthalmol 1985;103:1134-1135.